Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in “freeze-all” approach

M. Fernández-Sáncheza IVI-RMA Seville, Seville, Spain;b Department of Surgery, Universidad de Sevilla, Seville, Spain;c Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, Seville, Spain;d Fundacion IVI, Instituto Investigación Sanitaria La Fe, Valencia, SpainCorrespondence[email protected]
View further author information

H. Fatemie ART Fertility Clinics, Abu Dhabi, UAEView further author information

J. A. García-Velascod Fundacion IVI, Instituto Investigación Sanitaria La Fe, Valencia, Spain;f Reproductive Medicine Department, IVIRMA Madrid, Madrid, SpainView further author information

P. W. Heiserg Ferring Pharmaceuticals, Inc, Parsippany, New Jersey, USAView further author information

G. S. Daftaryg Ferring Pharmaceuticals, Inc, Parsippany, New Jersey, USAView further author information

B. Mannaertsh Reproductive Medicine & Maternal Health, Ferring Pharmaceuticals, Kastrup, DenmarkView further author information

Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in “freeze-all” approach

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in “freeze-all” approach

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date